Regenerative medicine is advancing faster than most people realize.

What once sounded like science fiction using your own cells to heal, regenerate, and even slow aging is quickly becoming a real and emerging pillar of healthcare. From stem cells to exosomes, breakthroughs are opening the door to treatments that don’t just manage symptoms, but actively repair the body at a cellular level.

Some believe this could redefine medicine entirely, shifting us from reactive care to personalized, biology-driven therapies. Others caution that the field is still early, with inconsistent data, evolving standards, and unanswered questions around safety and long-term outcomes.

Today, Drew Taylor breaks down the real state of regenerative medicine, from banking your own cells to the cutting-edge therapies already being used in skin, hair, and beyond. The real question is whether we’re witnessing the future of medicine, or just the beginning of a much longer journey.

Drew Taylor is a regenerative medicine expert and CEO of Acorn Biolabs, focused on making personalized cell therapies accessible by preserving and leveraging your own stem cells for future treatments.